Actavis Receives Approval Generic Inderal(R) LA Capsules In The U.S.
Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Propranolol Hydrochloride extended-release capsules. Distribution of the product will commence immediately.
